產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-ATP13A2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-ATP13A2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ATP13A2
Cat. Number:
Anti-ATP13A2抗體KL-11708R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
ATP13A2 is a 1,180 amino acid multi-pass membrane protein that belongs to the P5 subfamily of ATPases which play an important role in the transportation of inorganic cations. Expressed as multiple alternative Anti-ATP13A2抗體spliced isoforms, ATP13A2 functions to catalyze the conversion of ATP to ADP and a free phosphate, thereby participating in the active transport of ions across cellular membranes. Defects in the gene encoding ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS), a rare hereditary type of Parkinson’s disease that exhibits juvenile onset and is characterized by neurodegeneration and dementia. The ATP13A2 gene maps to human chromosome 1, which spans 260 million base pairs, contains over 3,000 genes and comprises nearly 8% of the human genome.
Also known as:
PARK9; AT132_HUMAN; Anti-ATP13A2抗體Atp13a2; ATPase type 13A2; CLN12; HSA9947; KRPPD; PARK9; Probable cation transporting ATPase 13A2; Probable cation-transporting ATPase 13A2; Putative ATPase; RP1-37C10.4.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ATP13A2 (1001-1080aa).
●
Predicted Molecular Weight: 129kDa.
Storage:
Shipped at 4℃,Anti-ATP13A2抗體 Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-ATP13A2抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-ATP13A2抗體dilutions must be determined by the end user.
kl781Hu01 CD276分子(CD276)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 276 (CD276)
kl782Ga01 碳酸酐酶Ⅱ(CA2)多克隆抗體 Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl782Hu01 碳酸酐酶Ⅱ(CA2)多克隆抗體 Polyclonal Antibody to Carbonic Anhydrase II (CA2)
kl783Hu01 補(bǔ)體因子P(CFP)多克隆抗體 Polyclonal Antibody to Complement Factor P (CFP)
kl785Hu01 腎損傷分子1(Kim1)多克隆抗體 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl785Mu01 腎損傷分子1(Kim1)多克隆抗體 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl785Ra01 腎損傷分子1(Kim1)多克隆抗體 Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl786Hu01 纖維膠凝蛋白1(FCN1)多克隆抗體 Polyclonal Antibody to Ficolin 1 (FCN1)
kl786Mu01 纖維膠凝蛋白1(FCN1)多克隆抗體 Polyclonal Antibody to Ficolin 1 (FCN1)
kl788Hu01 細(xì)胞程序性死亡蛋白1配體1(PDCD1LG1)多克隆抗體 Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDCD1LG1)
kl788Mu01 細(xì)胞程序性死亡蛋白1配體1(PDCD1LG1)多克隆抗體 Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDCD1LG1)
kl791Mu01 骨粘連蛋白(ON)多克隆抗體 Polyclonal Antibody to Osteonectin (ON)
kl791Ra01 骨粘連蛋白(ON)多克隆抗體 Polyclonal Antibody to Osteonectin (ON)
kl792Hu01 拓?fù)洚悩?gòu)酶Ⅱ(TOP2)多克隆抗體 Polyclonal Antibody to Topoisomerase II (TOP2)
kl794Hu01 周期素依賴(lài)性激酶抑制因子2A(CDKN2A)多克隆抗體 Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
kl794Mu01 周期素依賴(lài)性激酶抑制因子2A(CDKN2A)多克隆抗體 Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
kl796Hu01 神經(jīng)肽S(NPS)多克隆抗體 Polyclonal Antibody to Neuropeptide S (NPS)
